These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


285 related items for PubMed ID: 1589052

  • 41. Cyclosporin A in steroid-sensitive nephrotic syndrome with frequent relapses.
    Chan MK, Cheng IK.
    Postgrad Med J; 1987 Sep; 63(743):757-9. PubMed ID: 3444800
    [Abstract] [Full Text] [Related]

  • 42. The treatment of minimal change nephrotic syndrome (lipoid nephrosis): cooperative studies of the Arbeitsgemeinschaft für Pädiatrische Nephrologie (APN).
    Brodehl J, Krohn HP, Ehrich JH.
    Klin Padiatr; 1982 Sep; 194(3):162-5. PubMed ID: 6752557
    [Abstract] [Full Text] [Related]

  • 43. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome.
    Bajpai A, Bagga A, Hari P, Dinda A, Srivastava RN.
    Pediatr Nephrol; 2003 Apr; 18(4):351-6. PubMed ID: 12700961
    [Abstract] [Full Text] [Related]

  • 44. Beneficial effect of second courses of cytotoxic therapy in children with minimal change nephrotic syndrome.
    Jones DP, Stapleton FB, Roy S, Wyatt RJ.
    Pediatr Nephrol; 1988 Jul; 2(3):291-5. PubMed ID: 3153028
    [Abstract] [Full Text] [Related]

  • 45. Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie.
    Plank C, Kalb V, Hinkes B, Hildebrandt F, Gefeller O, Rascher W, Arbeitsgemeinschaft für Pädiatrische Nephrologie.
    Pediatr Nephrol; 2008 Sep; 23(9):1483-93. PubMed ID: 18481113
    [Abstract] [Full Text] [Related]

  • 46. Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome.
    Webb H, Jaureguiberry G, Dufek S, Tullus K, Bockenhauer D.
    Pediatr Nephrol; 2016 Apr; 31(4):589-94. PubMed ID: 26525199
    [Abstract] [Full Text] [Related]

  • 47. [Immunosuppressive therapy of the nephrotic syndrome in childhood].
    Brodehl J.
    Monatsschr Kinderheilkd (1902); 1972 Jun; 120(6):223-32. PubMed ID: 4560226
    [No Abstract] [Full Text] [Related]

  • 48. Long-term assessment of cyclophosphamide therapy for nephrosis in children.
    McDonald J, Murphy AV, Arneil GC.
    Lancet; 1974 Oct 26; 2(7887):980-2. PubMed ID: 4138088
    [No Abstract] [Full Text] [Related]

  • 49. Efficacy of methylprednisolone pulse therapy in steroid-resistant nephrotic syndrome.
    Mori K, Honda M, Ikeda M.
    Pediatr Nephrol; 2004 Nov 26; 19(11):1232-6. PubMed ID: 15322892
    [Abstract] [Full Text] [Related]

  • 50. Intravenous pulse cyclophosphamide--is it effective in children with steroid-resistant nephrotic syndrome?
    Alshaya HO, Al-Maghrabi JA, Kari JA.
    Pediatr Nephrol; 2003 Nov 26; 18(11):1143-6. PubMed ID: 13680329
    [Abstract] [Full Text] [Related]

  • 51. Late resistance to corticosteroids in nephrotic syndrome.
    Srivastava RN, Agarwal RK, Moudgil A, Bhuyan UN.
    J Pediatr; 1986 Jan 26; 108(1):66-70. PubMed ID: 3944696
    [Abstract] [Full Text] [Related]

  • 52. Rituximab in patients with the steroid-resistant nephrotic syndrome.
    Bagga A, Sinha A, Moudgil A.
    N Engl J Med; 2007 Jun 28; 356(26):2751-2. PubMed ID: 17596616
    [No Abstract] [Full Text] [Related]

  • 53. A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood.
    Chiu J, McLaine PN, Drummond KN.
    J Pediatr; 1973 Apr 28; 82(4):607-13. PubMed ID: 4698337
    [No Abstract] [Full Text] [Related]

  • 54. Steroid sensitive nephrotic syndrome in paediatrics.
    Nadir SJ, Saleem N, Amin F, Mahmood KT.
    Pak J Pharm Sci; 2011 Apr 28; 24(2):207-10. PubMed ID: 21454171
    [Abstract] [Full Text] [Related]

  • 55. Steroid-responsive relapsing nephrotic syndrome associated with early diabetic glomerulopathy in a child.
    Peces R, Riera JR, López Larrea C, Alvarez J.
    Nephron; 1987 Apr 28; 46(1):78-82. PubMed ID: 3600916
    [Abstract] [Full Text] [Related]

  • 56. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children.
    Lancet; 1974 Aug 24; 2(7878):423-7. PubMed ID: 4137139
    [No Abstract] [Full Text] [Related]

  • 57. Cyclophosphamide in treatment of minimal change nephrotic syndrome.
    Shohet I, Meyerovitch J, Aladjem M, Boichis H.
    Eur J Pediatr; 1988 Apr 24; 147(3):239-41. PubMed ID: 3391218
    [Abstract] [Full Text] [Related]

  • 58. Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide.
    Cameron JS, Chantler C, Ogg CS, White RH.
    Br Med J; 1974 Oct 05; 4(5935):7-11. PubMed ID: 4425844
    [Abstract] [Full Text] [Related]

  • 59. Treatment of the idiopathic nephrotic syndrome.
    Kleinknecht C, Broyer M, Jarde O, Guillot M.
    Paediatrician; 1981 Oct 05; 10(5-6):382-99. PubMed ID: 7036046
    [Abstract] [Full Text] [Related]

  • 60. [Results of the treatment of glomerulonephritis in children with hepatitis B].
    Ilamanov M, Naumova VI.
    Pediatriia; 1991 Oct 05; (7):91-4. PubMed ID: 1754336
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.